DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

Abstract

The positron emission tomography (PET) radiotracer Pittsburgh Compound-B (PiB) binds with high affinity to β-pleated sheet aggregates of the amyloid-β (Aβ) peptide in vitro. The in vivo retention of PiB in brains of people with Alzheimer's disease shows a regional distribution that is very similar to distribution of Aβ deposits observed post-mortem. However, the basis for regional variations in PiB binding in vivo, and the extent to which it binds to different types of Aβ-containing plaques and tau-containing neurofibrillary tangles (NFT), has not been thoroughly investigated. The present study examined 28 clinically diagnosed and autopsy-confirmed Alzheimer's disease subjects, including one Alzheimer's disease subject who had undergone PiB-PET imaging 10 months prior to death, to evaluate region- and substrate-specific binding of the highly fluorescent PiB derivative 6-CN-PiB. These data were then correlated with region-matched Aβ plaque load and peptide levels, [3H]PiB binding in vitro, and in vivo PET retention levels. We found that in Alzheimer's disease brain tissue sections, the preponderance of 6-CN-PiB binding is in plaques immunoreactive to either Aβ42 or Aβ40, and to vascular Aβ deposits. 6-CN-PiB labelling was most robust in compact/cored plaques in the prefrontal and temporal cortices. While diffuse plaques, including those in caudate nucleus andmore » presubiculum, were less prominently labelled, amorphous Aβ plaques in the cerebellum were not detectable with 6-CN-PiB. Only a small subset of NFT were 6-CN-PiB positive; these resembled extracellular ‘ghost’ NFT. In Alzheimer's disease brain tissue homogenates, there was a direct correlation between [3H]PiB binding and insoluble Aβ peptide levels. In the Alzheimer's disease subject who underwent PiB-PET prior to death, in vivo PiB retention levels correlated directly with region-matched post-mortem measures of [3H]PiB binding, insoluble Aβ peptide levels, 6-CN-PiB- and Aβ plaque load, but not with measures of NFT. These results demonstrate, in a typical Alzheimer's disease brain, that PiB binding is highly selective for insoluble (fibrillar) Aβ deposits, and not for neurofibrillary pathology. The strong direct correlation of in vivo PiB retention with region-matched quantitative analyses of Aβ plaques in the same subject supports the validity of PiB-PET imaging as a method for in vivo evaluation of Aβ plaque burden.« less

Authors:
 [1];  [2];  [3];  [4];  [4];  [5];  [4];  [4];  [4];  [3];  [5];  [3];  [3];  [6];  [7]
  1. Univ. of Pittsburgh, PA (United States). School of Medicine. Depts. of Neurology and Psychiatry
  2. Univ. of Pittsburgh, PA (United States). School of Medicine, Dept. of Psychiatry
  3. Univ. of Pittsburgh, PA (United States). School of Medicine, Dept. of Neurology
  4. Univ. of Pittsburgh, PA (United States). School of Medicine, Dept. of Radiology
  5. Univ. of Pittsburgh, PA (United States). School of Medicine, Dept. of Psychiatry
  6. Univ. of Pittsburgh, PA (United States). School of Medicine, Dept. of Neuropathology
  7. Univ. of Pittsburgh, PA (United States). School of Medicine, Depts. of Neurology and Psychiatry
Publication Date:
Research Org.:
Univ. of Pittsburgh, PA (United States)
Sponsoring Org.:
USDOE Office of Science (SC); National Institutes of Health (NIH); Alzheimer’s Association; Dana Foundation
OSTI Identifier:
1625298
Grant/Contract Number:  
FG02-03ER63590; AG05133; AG025516
Resource Type:
Accepted Manuscript
Journal Name:
Brain
Additional Journal Information:
Journal Volume: 131; Journal Issue: 6; Journal ID: ISSN 0006-8950
Publisher:
Oxford University Press
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; neurosciences & neurology; Pittsburgh Compound-B; PiB; amyloid imaging; plaques; PET imaging

Citation Formats

Ikonomovic, Milos D., Klunk, William E., Abrahamson, Eric E., Mathis, Chester A., Price, Julie C., Tsopelas, Nicholas D., Lopresti, Brian J., Ziolko, Scott, Bi, Wenzhu, Paljug, William R., Debnath, Manik L., Hope, Caroline E., Isanski, Barbara A., Hamilton, Ronald L., and DeKosky, Steven T. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. United States: N. p., 2008. Web. doi:10.1093/brain/awn016.
Ikonomovic, Milos D., Klunk, William E., Abrahamson, Eric E., Mathis, Chester A., Price, Julie C., Tsopelas, Nicholas D., Lopresti, Brian J., Ziolko, Scott, Bi, Wenzhu, Paljug, William R., Debnath, Manik L., Hope, Caroline E., Isanski, Barbara A., Hamilton, Ronald L., & DeKosky, Steven T. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. United States. https://doi.org/10.1093/brain/awn016
Ikonomovic, Milos D., Klunk, William E., Abrahamson, Eric E., Mathis, Chester A., Price, Julie C., Tsopelas, Nicholas D., Lopresti, Brian J., Ziolko, Scott, Bi, Wenzhu, Paljug, William R., Debnath, Manik L., Hope, Caroline E., Isanski, Barbara A., Hamilton, Ronald L., and DeKosky, Steven T. Wed . "Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease". United States. https://doi.org/10.1093/brain/awn016. https://www.osti.gov/servlets/purl/1625298.
@article{osti_1625298,
title = {Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease},
author = {Ikonomovic, Milos D. and Klunk, William E. and Abrahamson, Eric E. and Mathis, Chester A. and Price, Julie C. and Tsopelas, Nicholas D. and Lopresti, Brian J. and Ziolko, Scott and Bi, Wenzhu and Paljug, William R. and Debnath, Manik L. and Hope, Caroline E. and Isanski, Barbara A. and Hamilton, Ronald L. and DeKosky, Steven T.},
abstractNote = {The positron emission tomography (PET) radiotracer Pittsburgh Compound-B (PiB) binds with high affinity to β-pleated sheet aggregates of the amyloid-β (Aβ) peptide in vitro. The in vivo retention of PiB in brains of people with Alzheimer's disease shows a regional distribution that is very similar to distribution of Aβ deposits observed post-mortem. However, the basis for regional variations in PiB binding in vivo, and the extent to which it binds to different types of Aβ-containing plaques and tau-containing neurofibrillary tangles (NFT), has not been thoroughly investigated. The present study examined 28 clinically diagnosed and autopsy-confirmed Alzheimer's disease subjects, including one Alzheimer's disease subject who had undergone PiB-PET imaging 10 months prior to death, to evaluate region- and substrate-specific binding of the highly fluorescent PiB derivative 6-CN-PiB. These data were then correlated with region-matched Aβ plaque load and peptide levels, [3H]PiB binding in vitro, and in vivo PET retention levels. We found that in Alzheimer's disease brain tissue sections, the preponderance of 6-CN-PiB binding is in plaques immunoreactive to either Aβ42 or Aβ40, and to vascular Aβ deposits. 6-CN-PiB labelling was most robust in compact/cored plaques in the prefrontal and temporal cortices. While diffuse plaques, including those in caudate nucleus and presubiculum, were less prominently labelled, amorphous Aβ plaques in the cerebellum were not detectable with 6-CN-PiB. Only a small subset of NFT were 6-CN-PiB positive; these resembled extracellular ‘ghost’ NFT. In Alzheimer's disease brain tissue homogenates, there was a direct correlation between [3H]PiB binding and insoluble Aβ peptide levels. In the Alzheimer's disease subject who underwent PiB-PET prior to death, in vivo PiB retention levels correlated directly with region-matched post-mortem measures of [3H]PiB binding, insoluble Aβ peptide levels, 6-CN-PiB- and Aβ plaque load, but not with measures of NFT. These results demonstrate, in a typical Alzheimer's disease brain, that PiB binding is highly selective for insoluble (fibrillar) Aβ deposits, and not for neurofibrillary pathology. The strong direct correlation of in vivo PiB retention with region-matched quantitative analyses of Aβ plaques in the same subject supports the validity of PiB-PET imaging as a method for in vivo evaluation of Aβ plaque burden.},
doi = {10.1093/brain/awn016},
journal = {Brain},
number = 6,
volume = 131,
place = {United States},
year = {Wed Mar 12 00:00:00 EDT 2008},
month = {Wed Mar 12 00:00:00 EDT 2008}
}

Works referenced in this record:

Neuropathological stageing of Alzheimer-related changes
journal, September 1991


Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
journal, September 1996


Diagnosis of Alzheimer's disease
journal, January 1991


Imaging β-Amyloid Plaques and Neurofibrillary Tangles in the Aging Human Brain
journal, May 2004


Association of Increased Cortical Soluble Aβ42 Levels With Diffuse Plaques After Severe Brain Injury in Humans
journal, April 2007

  • DeKosky, Steven T.; Abrahamson, Eric E.; Ciallella, John R.
  • Archives of Neurology, Vol. 64, Issue 4
  • DOI: 10.1001/archneur.64.4.541

Erratum: Biomarkers of Alzheimer Disease
journal, August 2013


Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles.
journal, March 1991

  • Tabaton, M.; Cammarata, S.; Mancardi, G.
  • Proceedings of the National Academy of Sciences, Vol. 88, Issue 6
  • DOI: 10.1073/pnas.88.6.2098

The “Nonamyloidogenic” p3 Fragment (Amyloid β17-42) Is a Major Constituent of Down's Syndrome Cerebellar Preamyloid
journal, December 1996

  • Lalowski, Maciej; Golabek, Adam; Lemere, Cynthia A.
  • Journal of Biological Chemistry, Vol. 271, Issue 52
  • DOI: 10.1074/jbc.271.52.33623

The Role of Biomarkers in Clinical Trials for Alzheimer Disease
journal, January 2006


Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP
journal, December 2001

  • Kamal, Adeela; Almenar-Queralt, Angels; LeBlanc, James F.
  • Nature, Vol. 414, Issue 6864
  • DOI: 10.1038/414643a

Pyroglutamate-modified amyloid β-peptides - AβN3(pE) - strongly affect cultured neuron and astrocyte survival: N-modified amyloid-β severely affect neurones
journal, September 2002


Amyloid β Protein Starting Pyroglutamate at Position 3 Is a Major Component of the Amyloid Deposits in the Alzheimer's Disease Brain
journal, September 2000

  • Harigaya, Yasuo; Saido, Takaomi C.; Eckman, Christopher B.
  • Biochemical and Biophysical Research Communications, Vol. 276, Issue 2
  • DOI: 10.1006/bbrc.2000.3490

Missorting of Tau in Neurons Causes Degeneration of Synapses That Can Be Rescued by the Kinase MARK2/Par-1
journal, March 2007


Monitoring pathological assembly of tau and ?-amyloid proteins in Alzheimer's disease
journal, January 1995

  • Mena, Ra�l; Edwards, Patricia; P�rez-Olvera, Ofelia
  • Acta Neuropathologica, Vol. 89, Issue 1
  • DOI: 10.1007/BF00294259

PET of Brain Amyloid and Tau in Mild Cognitive Impairment
journal, December 2006

  • Small, Gary W.; Kepe, Vladimir; Ercoli, Linda M.
  • New England Journal of Medicine, Vol. 355, Issue 25
  • DOI: 10.1056/NEJMoa054625

Diagnosis of Alzheimer's disease.
journal, February 1991


Diagnosis of Alzheimerʼs Disease in a Community Hospital-Based Brain Bank Program
journal, January 1997


Aβ Species Removal After Aβ 42 Immunization
journal, November 2006


Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I
journal, December 2000


Role of biomarkers in studies of presymptomatic Alzheimer's disease
journal, October 2005


Alzheimer patients and Down patients: Cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques
journal, November 1989


Mild cognitive impairment
journal, April 2006


Synthesis and Evaluation of 11 C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents
journal, June 2003

  • Mathis, Chester A.; Wang, Yanming; Holt, Daniel P.
  • Journal of Medicinal Chemistry, Vol. 46, Issue 13
  • DOI: 10.1021/jm030026b

Diagnosis of Alzheimer's Disease
journal, November 1985


Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease
journal, April 1998


PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
journal, October 2007


Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II
journal, December 2000


The Binding of 2-(4′-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid Component
journal, March 2003


Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
journal, September 2006


Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B: Imaging Amyloid in AD with PIB
journal, January 2004

  • Klunk, William E.; Engler, Henry; Nordberg, Agneta
  • Annals of Neurology, Vol. 55, Issue 3
  • DOI: 10.1002/ana.20009

Imaging  -amyloid burden in aging and dementia
journal, May 2007


Molecular Imaging With Pittsburgh Compound B Confirmed at Autopsy: A Case Report
journal, March 2007

  • Bacskai, Brian J.; Frosch, Matthew P.; Freeman, Stefanie H.
  • Archives of Neurology, Vol. 64, Issue 3
  • DOI: 10.1001/archneur.64.3.431

Topographical relationship between beta-amyloid and tau protein epitopes in tangle-bearing cells in Alzheimer disease.
journal, May 1990

  • Spillantini, M. G.; Goedert, M.; Jakes, R.
  • Proceedings of the National Academy of Sciences, Vol. 87, Issue 10
  • DOI: 10.1073/pnas.87.10.3952

Simplified Reference Tissue Model for PET Receptor Studies
journal, December 1996


Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
journal, September 2007

  • Johnson, Keith A.; Gregas, Matt; Becker, John A.
  • Annals of Neurology, Vol. 62, Issue 3
  • DOI: 10.1002/ana.21164

Biological Markers of Alzheimer’s Disease
journal, March 1998


Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease
journal, February 1998


Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease
journal, May 1996

  • Mena, R.; Edwards, Patricia C.; Harrington, Charles R.
  • Acta Neuropathologica, Vol. 91, Issue 6
  • DOI: 10.1007/s004010050477

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain
journal, August 2001


Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes
journal, August 1992

  • Mercken, Marc; Vandermeeren, Marc; Lübke, Ursula
  • Acta Neuropathologica, Vol. 84, Issue 3
  • DOI: 10.1007/BF00227819

X‐34 Labeling of Abnormal Protein Aggregates During the Progression of Alzheimer's Disease
book, January 2006


A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain
journal, February 2002

  • Mathis, Chester A.; Bacskai, Brian J.; Kajdasz, Stephen T.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 12, Issue 3
  • DOI: 10.1016/S0960-894X(01)00734-X

Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B
journal, May 2005

  • Price, Julie C.; Klunk, William E.; Lopresti, Brian J.
  • Journal of Cerebral Blood Flow & Metabolism, Vol. 25, Issue 11
  • DOI: 10.1038/sj.jcbfm.9600146

Kunitz Protease Inhibitor-Containing Amyloid β Protein Precursor Immunoreactivity in Alzheimer's Disease
journal, January 1992


A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
journal, March 1984

  • Mintun, Mark A.; Raichle, Marcus E.; Kilbourn, Michael R.
  • Annals of Neurology, Vol. 15, Issue 3
  • DOI: 10.1002/ana.410150302

Imaging Technology for Neurodegenerative Diseases: Progress Toward Detection of Specific Pathologies
journal, February 2005

  • Mathis, Chester A.; Klunk, William E.; Price, Julie C.
  • Archives of Neurology, Vol. 62, Issue 2
  • DOI: 10.1001/archneur.62.2.196

Biomarkers of Alzheimer Disease
journal, March 1999


PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment
journal, May 2007


Biological markers of Alzheimer's disease
journal, April 1990


A4 amyloid protein immunoreactivity is present in Alzheimer's disease neurofibrillary tangles
journal, July 1989


Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease.
journal, April 1989

  • Grundke-Iqbal, I.; Iqbal, K.; George, L.
  • Proceedings of the National Academy of Sciences, Vol. 86, Issue 8
  • DOI: 10.1073/pnas.86.8.2853

Diagnosis of Alzheimer's Disease
journal, November 1985


Biomarkers of Alzheimer Disease
journal, March 1999


An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease
journal, January 1992

  • Guntern, R.; Bouras, C.; Hof, P. R.
  • Experientia, Vol. 48, Issue 1
  • DOI: 10.1007/bf01923594

Alzheimer patients and Down patients: Cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques
journal, November 1989


Role of biomarkers in studies of presymptomatic Alzheimer's disease
journal, October 2005


Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography
journal, November 2003


Synthesis and Evaluation of 11 C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents
journal, June 2003

  • Mathis, Chester A.; Wang, Yanming; Holt, Daniel P.
  • Journal of Medicinal Chemistry, Vol. 46, Issue 13
  • DOI: 10.1021/jm030026b

Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP
journal, December 2001

  • Kamal, Adeela; Almenar-Queralt, Angels; LeBlanc, James F.
  • Nature, Vol. 414, Issue 6864
  • DOI: 10.1038/414643a

Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B
journal, May 2005

  • Price, Julie C.; Klunk, William E.; Lopresti, Brian J.
  • Journal of Cerebral Blood Flow & Metabolism, Vol. 25, Issue 11
  • DOI: 10.1038/sj.jcbfm.9600146

Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease.
journal, April 1989

  • Grundke-Iqbal, I.; Iqbal, K.; George, L.
  • Proceedings of the National Academy of Sciences, Vol. 86, Issue 8
  • DOI: 10.1073/pnas.86.8.2853

Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles.
journal, March 1991

  • Tabaton, M.; Cammarata, S.; Mancardi, G.
  • Proceedings of the National Academy of Sciences, Vol. 88, Issue 6
  • DOI: 10.1073/pnas.88.6.2098

Kunitz Protease Inhibitor-Containing Amyloid β Protein Precursor Immunoreactivity in Alzheimer's Disease
journal, January 1992


The Role of Biomarkers in Clinical Trials for Alzheimer Disease
journal, January 2006


In Vitro Characterization of Pittsburgh Compound-B Binding to Lewy Bodies
journal, September 2007


Works referencing / citing this record:

Synthesis and Evaluation of a Zr-89-Labeled Monoclonal Antibody for Immuno-PET Imaging of Amyloid-β Deposition in the Brain
journal, February 2016

  • Fissers, Jens; Waldron, Ann-Marie; De Vijlder, Thomas
  • Molecular Imaging and Biology, Vol. 18, Issue 4
  • DOI: 10.1007/s11307-016-0935-z

Pittsburgh compound B and the postmortem diagnosis of alzheimer disease
journal, October 2012

  • Niedowicz, Dana M.; Beckett, Tina L.; Matveev, Sergey
  • Annals of Neurology, Vol. 72, Issue 4
  • DOI: 10.1002/ana.23633

Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial
journal, July 2015

  • Kim, Hee Jin; Seo, Sang Won; Chang, Jong Wook
  • Alzheimer's & Dementia: Translational Research & Clinical Interventions, Vol. 1, Issue 2
  • DOI: 10.1016/j.trci.2015.06.007

Cerebral Amyloid Angiopathy, Alzheimer’s Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets
journal, October 2019

  • Weldon Furr, J.; Morales-Scheihing, Diego; Manwani, Bharti
  • NeuroMolecular Medicine, Vol. 21, Issue 4
  • DOI: 10.1007/s12017-019-08568-0

Quantitative imaging of protein targets in the human brain with PET
journal, October 2015


Reference tissue normalization in longitudinal 18F-florbetapir positron emission tomography of late mild cognitive impairment
journal, January 2016

  • Shokouhi, Sepideh; Mckay, John W.; Baker, Suzanne L.
  • Alzheimer's Research & Therapy, Vol. 8, Issue 1
  • DOI: 10.1186/s13195-016-0172-3

Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease
journal, October 2018


Cerebral amyloid PET imaging in Alzheimer’s disease
journal, October 2013

  • Jack, Clifford R.; Barrio, Jorge R.; Kepe, Vladimir
  • Acta Neuropathologica, Vol. 126, Issue 5
  • DOI: 10.1007/s00401-013-1185-7

Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B
journal, November 2012

  • Handen, Benjamin L.; Cohen, Ann D.; Channamalappa, Umapathy
  • Alzheimer's & Dementia, Vol. 8, Issue 6
  • DOI: 10.1016/j.jalz.2011.09.229

2018 Alzheimer's disease facts and figures
journal, January 2018


Human apoE Isoforms Differentially Regulate Brain Amyloid-  Peptide Clearance
journal, June 2011


APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study
journal, February 2013

  • Ramanan, V. K.; Risacher, S. L.; Nho, K.
  • Molecular Psychiatry, Vol. 19, Issue 3
  • DOI: 10.1038/mp.2013.19

Invited Review: The spectrum of age‐related small vessel diseases: potential overlap and interactions of amyloid and nonamyloid vasculopathies
journal, September 2019

  • Schreiber, S.; Wilisch‐Neumann, A.; Schreiber, F.
  • Neuropathology and Applied Neurobiology, Vol. 46, Issue 3
  • DOI: 10.1111/nan.12576

Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia
journal, October 2008

  • Rabinovici, Gil D.; Jagust, William J.; Furst, Ansgar J.
  • Annals of Neurology, Vol. 64, Issue 4
  • DOI: 10.1002/ana.21451

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
journal, March 2011

  • Fodero-Tavoletti, M. T.; Okamura, N.; Furumoto, S.
  • Brain, Vol. 134, Issue 4
  • DOI: 10.1093/brain/awr038

Imaging Alzheimer's disease pathophysiology with PET
journal, June 2016


Fibrillar amyloid-  burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
journal, April 2009

  • Reiman, E. M.; Chen, K.; Liu, X.
  • Proceedings of the National Academy of Sciences, Vol. 106, Issue 16
  • DOI: 10.1073/pnas.0900345106

Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
journal, May 2015

  • Villeneuve, Sylvia; Rabinovici, Gil D.; Cohn-Sheehy, Brendan I.
  • Brain, Vol. 138, Issue 7
  • DOI: 10.1093/brain/awv112

Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer’s disease
journal, July 2015

  • Zhang, Xueli; Tian, Yanli; Zhang, Can
  • Proceedings of the National Academy of Sciences, Vol. 112, Issue 31
  • DOI: 10.1073/pnas.1505420112

Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand: AZD4694 a new amyloid PET radioligand
journal, June 2010


Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology
journal, July 2013

  • Perez-Nievas, Beatriz G.; Stein, Thor D.; Tai, Hwan-Ching
  • Brain, Vol. 136, Issue 8
  • DOI: 10.1093/brain/awt171

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program: Arizona Brain and Body Donation Program
journal, January 2015

  • Beach, Thomas G.; Adler, Charles H.; Sue, Lucia I.
  • Neuropathology, Vol. 35, Issue 4
  • DOI: 10.1111/neup.12189

Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients
journal, January 2013

  • Saint-Aubert, Laure; Barbeau, Emmanuel J.; Péran, Patrice
  • EJNMMI Research, Vol. 3, Issue 1
  • DOI: 10.1186/2191-219x-3-43

β-Amyloid is Associated with Aberrant Metabolic Connectivity in Subjects with Mild Cognitive Impairment
journal, April 2014

  • Carbonell, Felix; Charil, Arnaud; Zijdenbos, Alex P.
  • Journal of Cerebral Blood Flow & Metabolism, Vol. 34, Issue 7
  • DOI: 10.1038/jcbfm.2014.66

Is Olfactory Epithelium Biopsy Useful for Confirming Alzheimer’s Disease?
journal, December 2018

  • Godoy, Maria Dantas Costa Lima; Fornazieri, Marco Aurélio; Doty, Richard L.
  • Annals of Otology, Rhinology & Laryngology, Vol. 128, Issue 3
  • DOI: 10.1177/0003489418814865

AZD2184: a radioligand for sensitive detection of β-amyloid deposits
journal, March 2009


Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease
journal, January 2012

  • Villemagne, Victor L.; Klunk, William E.; Mathis, Chester A.
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Issue 2
  • DOI: 10.1007/s00259-011-2045-0

Correspondence between in vivo 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques
journal, August 2012


Hypertension and obesity moderate the relationship between β-amyloid and cognitive decline in midlife
journal, October 2018

  • Clark, Lindsay R.; Koscik, Rebecca L.; Allison, Samantha L.
  • Alzheimer's & Dementia, Vol. 15, Issue 3
  • DOI: 10.1016/j.jalz.2018.09.008

Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy
journal, December 2019

  • Padovani, Alessandro; Benussi, Alberto; Cotelli, Maria Sofia
  • Alzheimer's Research & Therapy, Vol. 11, Issue 1
  • DOI: 10.1186/s13195-019-0555-3

Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases
journal, January 2017

  • Madeira, Maria H.; Boia, Raquel; Ambrósio, António F.
  • Mediators of Inflammation, Vol. 2017
  • DOI: 10.1155/2017/4761081

Multisite study of the relationships between antemortem [ 11 C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
journal, October 2018


Functional Alterations in Memory Networks in Early Alzheimer’s Disease
journal, January 2010

  • Sperling, Reisa A.; Dickerson, Bradford C.; Pihlajamaki, Maija
  • NeuroMolecular Medicine, Vol. 12, Issue 1
  • DOI: 10.1007/s12017-009-8109-7

Community perceptions related to brain donation: Evidence for intervention
journal, October 2018

  • Striley, Catherine W.; Milani, Sadaf A.; Kwiatkowski, Evan
  • Alzheimer's & Dementia, Vol. 15, Issue 2
  • DOI: 10.1016/j.jalz.2018.09.005

Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18 F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls
journal, April 2010

  • Devanand, D. P.; Mikhno, Arthur; Pelton, Gregory H.
  • Journal of Geriatric Psychiatry and Neurology, Vol. 23, Issue 3
  • DOI: 10.1177/0891988710363715

Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels
journal, October 2009


The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease
journal, September 2018

  • Benussi, Alberto; Alberici, Antonella; Ferrari, Clarissa
  • Alzheimer's Research & Therapy, Vol. 10, Issue 1
  • DOI: 10.1186/s13195-018-0423-6

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
journal, July 2016

  • Leuzy, Antoine; Chiotis, Konstantinos; Hasselbalch, Steen G.
  • Brain, Vol. 139, Issue 9
  • DOI: 10.1093/brain/aww160

The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features
journal, July 2015

  • Ossenkoppele, Rik; Pijnenburg, Yolande A. L.; Perry, David C.
  • Brain, Vol. 138, Issue 9
  • DOI: 10.1093/brain/awv191

Mitochondrial ATP synthase activity is impaired by suppressed O -GlcNAcylation in Alzheimer's disease
journal, September 2015

  • Cha, Moon-Yong; Cho, Hyun Jin; Kim, Chaeyoung
  • Human Molecular Genetics, Vol. 24, Issue 22
  • DOI: 10.1093/hmg/ddv358

Should we disclose amyloid imaging results to cognitively normal individuals?
journal, February 2013

  • Grill, Joshua D.; Johnson, David K.; Burns, Jeffrey M.
  • Neurodegenerative Disease Management, Vol. 3, Issue 1
  • DOI: 10.2217/nmt.12.75

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
journal, February 2013

  • Johnson, Keith A.; Sperling, Reisa A.; Gidicsin, Christopher M.
  • Alzheimer's & Dementia, Vol. 9, Issue 5S
  • DOI: 10.1016/j.jalz.2012.10.007

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
journal, December 2016

  • Ikonomovic, Milos D.; Buckley, Chris J.; Heurling, Kerstin
  • Acta Neuropathologica Communications, Vol. 4, Issue 1
  • DOI: 10.1186/s40478-016-0399-z

Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer’s disease: why it is time to abandon the approach
journal, October 2019

  • Alavi, Abass; Barrio, Jorge R.; Werner, Thomas J.
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Issue 2
  • DOI: 10.1007/s00259-019-04564-5

Alzheimer’s Prevention Initiative: a proposal to evaluate presymptomatic treatments as quickly as possible
journal, February 2010

  • Reiman, Eric M.; Langbaum, Jessica BS; Tariot, Pierre N.
  • Biomarkers in Medicine, Vol. 4, Issue 1
  • DOI: 10.2217/bmm.09.91

Performance of [ 18 F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease
journal, January 2017

  • Salloway, Stephen; Gamez, Jose E.; Singh, Upinder
  • Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol. 9, Issue 1
  • DOI: 10.1016/j.dadm.2017.06.001

Quantitative Analysis of Brain 18F-fluordesoxyglucose and Early-Phase 18F-florbetapir Positron Emission Tomography
book, September 2019


Neuropathological correlates of amyloid PET imaging in Down syndrome
journal, July 2019

  • Abrahamson, Eric E.; Head, Elizabeth; Lott, Ira T.
  • Developmental Neurobiology, Vol. 79, Issue 7
  • DOI: 10.1002/dneu.22713

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
journal, January 2010

  • Morris, John C.; Roe, Catherine M.; Xiong, Chengjie
  • Annals of Neurology, Vol. 67, Issue 1
  • DOI: 10.1002/ana.21843

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
journal, March 2015


Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
journal, December 2014

  • Mattsson, Niklas; Insel, Philip S.; Donohue, Michael
  • Brain, Vol. 138, Issue 3
  • DOI: 10.1093/brain/awu367

Highly efficient solid phase supported radiosynthesis of [ 11 C]PiB using tC18 cartridge as a “3-in-1” production entity
journal, November 2017

  • Boudjemeline, Mehdi; Hopewell, Robert; Rochon, Pierre-Luc
  • Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 60, Issue 14
  • DOI: 10.1002/jlcr.3569

Clinicopathologic and 11 C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum
journal, March 2015

  • Murray, Melissa E.; Lowe, Val J.; Graff-Radford, Neill R.
  • Brain, Vol. 138, Issue 5
  • DOI: 10.1093/brain/awv050

The challenges of tau imaging
journal, July 2012

  • Villemagne, Victor L.; Furumoto, Shozo; Fodero-Tavoletti, Michelle
  • Future Neurology, Vol. 7, Issue 4
  • DOI: 10.2217/fnl.12.34

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
journal, January 2012

  • Camus, V.; Payoux, P.; Barré, L.
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Issue 4
  • DOI: 10.1007/s00259-011-2021-8

Imaging Brain Effects of APOE4 in Cognitively Normal Individuals Across the Lifespan
journal, August 2014

  • Fouquet, Marine; Besson, Florent L.; Gonneaud, Julie
  • Neuropsychology Review, Vol. 24, Issue 3
  • DOI: 10.1007/s11065-014-9263-8

Diagnostic accuracy of 18F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis
journal, November 2015

  • Morris, Elizabeth; Chalkidou, Anastasia; Hammers, Alexander
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, Issue 2
  • DOI: 10.1007/s00259-015-3228-x

Brain amyloid and cognition in Lewy body diseases
journal, June 2012

  • Gomperts, Stephen N.; Locascio, Joseph J.; Marquie, Marta
  • Movement Disorders, Vol. 27, Issue 8
  • DOI: 10.1002/mds.25048

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
journal, December 2019


In vivo characterization of the early states of the amyloid-beta network
journal, June 2013

  • Sepulcre, Jorge; Sabuncu, Mert R.; Becker, Alex
  • Brain, Vol. 136, Issue 7
  • DOI: 10.1093/brain/awt146

The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
journal, June 2016

  • Gordon, Brian A.; Friedrichsen, Karl; Brier, Matthew
  • Brain, Vol. 139, Issue 8
  • DOI: 10.1093/brain/aww139

CSF A β 42/A β 40 and A β 42/A β 38 ratios: better diagnostic markers of Alzheimer disease
journal, January 2016

  • Janelidze, Shorena; Zetterberg, Henrik; Mattsson, Niklas
  • Annals of Clinical and Translational Neurology, Vol. 3, Issue 3
  • DOI: 10.1002/acn3.274

Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue
journal, June 2013


PET imaging of brain amyloid in dementia: a review
journal, December 2010

  • Quigley, Harriet; Colloby, Sean J.; O'Brien, John T.
  • International Journal of Geriatric Psychiatry, Vol. 26, Issue 10
  • DOI: 10.1002/gps.2640

The clinical safety, biodistribution and internal radiation dosimetry of flutemetamol (18F) injection in healthy Japanese adult volunteers
journal, June 2015


Amyloid imaging, risk disclosure and Alzheimer’s disease: ethical and practical issues
journal, June 2013

  • Roberts, J. Scott; Dunn, Laura B.; Rabinovici, Gil D.
  • Neurodegenerative Disease Management, Vol. 3, Issue 3
  • DOI: 10.2217/nmt.13.25

Parenchymal and vascular Aβ-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease
journal, July 2008


The search for a unique Raman signature of amyloid-beta plaques in human brain tissue from Alzheimer's disease patients
journal, January 2020

  • Lochocki, Benjamin; Morrema, Tjado H. J.; Ariese, Freek
  • The Analyst, Vol. 145, Issue 5
  • DOI: 10.1039/c9an02087j

Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association
journal, January 2013

  • Johnson, Keith A.; Minoshima, Satoshi; Bohnen, Nicolaas I.
  • Journal of Nuclear Medicine, Vol. 54, Issue 3
  • DOI: 10.2967/jnumed.113.120618

Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy
journal, February 2009

  • Weller, Roy O.; Boche, Delphine; Nicoll, James A. R.
  • Acta Neuropathologica, Vol. 118, Issue 1
  • DOI: 10.1007/s00401-009-0498-z

Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease
journal, October 2010

  • Leinonen, Ville; Koivisto, Anne M.; Savolainen, Sakari
  • Annals of Neurology, Vol. 68, Issue 4
  • DOI: 10.1002/ana.22100

The use of PET in Alzheimer disease
journal, February 2010


Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer’s disease pathology
journal, October 2012

  • Harada, Ryuichi; Okamura, Nobuyuki; Furumoto, Shozo
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Issue 1
  • DOI: 10.1007/s00259-012-2261-2

18 F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial: 18 F-Flutemetamol Phase 2 Trial
journal, August 2010

  • Vandenberghe, Rik; Van Laere, Koen; Ivanoiu, Adrian
  • Annals of Neurology, Vol. 68, Issue 3
  • DOI: 10.1002/ana.22068

Mild to moderate Alzheimer dementia with insufficient neuropathological changes: PRAD with insufficient AD lesions
journal, April 2014

  • Serrano-Pozo, Alberto; Qian, Jing; Monsell, Sarah E.
  • Annals of Neurology, Vol. 75, Issue 4
  • DOI: 10.1002/ana.24125

Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
journal, February 2018

  • Villemagne, Victor L.; Doré, Vincent; Burnham, Samantha C.
  • Nature Reviews Neurology, Vol. 14, Issue 4
  • DOI: 10.1038/nrneurol.2018.9

Half-curcumin analogues as PET imaging probes for amyloid beta species
journal, January 2019

  • Yang, Jian; Cheng, Ran; Fu, Hualong
  • Chemical Communications, Vol. 55, Issue 25
  • DOI: 10.1039/c8cc10166c

Dementia spectrum disorders: lessons learnt from decades with PET research
journal, February 2019

  • Wilson, Heather; Pagano, Gennaro; Politis, Marios
  • Journal of Neural Transmission, Vol. 126, Issue 3
  • DOI: 10.1007/s00702-019-01975-4

Recent progress in the development of metal complexes as β-amyloid imaging probes in the brain
journal, January 2017


Regional brain hypometabolism is unrelated to regional amyloid plaque burden
journal, September 2015


Disclosure of amyloid imaging results to research participants: Has the time come?
journal, February 2013


A kinetics-based approach to amyloid PET semi-quantification
journal, January 2020

  • Chincarini, A.; Peira, E.; Corosu, M.
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Issue 9
  • DOI: 10.1007/s00259-020-04689-y

Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease
journal, March 2016

  • Pascoal, T. A.; Mathotaarachchi, S.; Mohades, S.
  • Molecular Psychiatry, Vol. 22, Issue 2
  • DOI: 10.1038/mp.2016.37

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
journal, July 2011

  • Toledo, Jon B.; Vanderstichele, Hugo; Figurski, Michal
  • Acta Neuropathologica, Vol. 122, Issue 4
  • DOI: 10.1007/s00401-011-0861-8

Molecular imaging in dementia: Past, present, and future
journal, July 2018


Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study
journal, November 2019


Update on biomarkers for amyloid pathology in Alzheimer's disease
journal, July 2018

  • Ashton, Nicholas J.; Schöll, Michael; Heurling, Kerstin
  • Biomarkers in Medicine, Vol. 12, Issue 7
  • DOI: 10.2217/bmm-2017-0433

Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer’s disease
journal, January 2013


Amyloid imaging in mild cognitive impairment subtypes
journal, May 2009

  • Wolk, David A.; Price, Julie C.; Saxton, Judy A.
  • Annals of Neurology, Vol. 65, Issue 5
  • DOI: 10.1002/ana.21598

Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer’s disease
journal, March 2015

  • Canobbio, Ilaria; Abubaker, Aisha Alsheikh; Visconte, Caterina
  • Frontiers in Cellular Neuroscience, Vol. 9
  • DOI: 10.3389/fncel.2015.00065

Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications
journal, November 2011

  • Laforce, Robert; Rabinovici, Gil D.
  • Alzheimer's Research & Therapy, Vol. 3, Issue 6
  • DOI: 10.1186/alzrt93

Preventive immunization of aged and juvenile non-human primates to beta-amyloid
journal, May 2012

  • Kofler, Julia; Lopresti, Brian; Janssen, Chris
  • Journal of Neuroinflammation, Vol. 9, Issue 1
  • DOI: 10.1186/1742-2094-9-84

Quantitative structural MRI for early detection of Alzheimer’s disease
journal, November 2010

  • McEvoy, Linda K.; Brewer, James B.
  • Expert Review of Neurotherapeutics, Vol. 10, Issue 11
  • DOI: 10.1586/ern.10.162

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
journal, August 2019

  • Chandra, Avinash; Valkimadi, Polytimi‐Eleni; Pagano, Gennaro
  • Human Brain Mapping, Vol. 40, Issue 18
  • DOI: 10.1002/hbm.24782

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
journal, April 2018


Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease
journal, March 2012

  • Villemagne, Victor L.; Mulligan, Rachel S.; Pejoska, Svetlana
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Issue 6
  • DOI: 10.1007/s00259-012-2088-x

[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer’s disease
journal, October 2013

  • Hatashita, Shizuo; Yamasaki, Hidetomo; Suzuki, Yutaka
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, Issue 2
  • DOI: 10.1007/s00259-013-2564-y

Preclinical Evaluation of [18F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer
journal, July 2015

  • Tago, Tetsuro; Furumoto, Shozo; Okamura, Nobuyuki
  • Molecular Imaging and Biology, Vol. 18, Issue 2
  • DOI: 10.1007/s11307-015-0879-8

Hippocampal Endosomal, Lysosomal, and Autophagic Dysregulation in Mild Cognitive Impairment: Correlation With Aβ and Tau Pathology
journal, April 2015

  • Perez, Sylvia E.; He, Bin; Nadeem, Muhammad
  • Journal of Neuropathology & Experimental Neurology, Vol. 74, Issue 4
  • DOI: 10.1097/nen.0000000000000179

[18F]-Florbetapir PET: Towards Predicting Dementia in Adults with Down Syndrome
posted_content, February 2018

  • Keator, David B.; Doran, Eric; Van Erp, Theo G. M.
  • DOI: 10.1101/235440

Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes
journal, January 2017

  • Tan, Rachel H.; Kril, Jillian J.; Yang, Yue
  • Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol. 9, Issue 1
  • DOI: 10.1016/j.dadm.2017.05.005

Relationships between Beta-Amyloid and Functional Connectivity in Different Components of the Default Mode Network in Aging
journal, March 2011

  • Mormino, Elizabeth C.; Smiljic, Andre; Hayenga, Amynta O.
  • Cerebral Cortex, Vol. 21, Issue 10
  • DOI: 10.1093/cercor/bhr025

Brain tissue Aβ42 levels are linked to shunt response in idiopathic normal pressure hydrocephalus
journal, January 2018

  • Abu Hamdeh, Sami; Virhammar, Johan; Sehlin, Dag
  • Journal of Neurosurgery, Vol. 130, Issue 1
  • DOI: 10.3171/2017.7.jns171005

Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden
journal, January 2010

  • Rabinovici, Gil D.; Furst, Ansgar J.; Alkalay, Adi
  • Brain, Vol. 133, Issue 2
  • DOI: 10.1093/brain/awp326

The correlation between striatal and cortical binding ratio of 11C-PiB-PET in amyloid-uptake-positive patients
journal, May 2018

  • Sauerbeck, Julia; Ishii, Kazunari; Hosokawa, Chisa
  • Annals of Nuclear Medicine, Vol. 32, Issue 6
  • DOI: 10.1007/s12149-018-1258-8

Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
journal, July 2017

  • Erkkinen, Michael G.; Kim, Mee-Ohk; Geschwind, Michael D.
  • Cold Spring Harbor Perspectives in Biology, Vol. 10, Issue 4
  • DOI: 10.1101/cshperspect.a033118

Neuroimaging of Alzheimer’s disease: focus on amyloid and tau PET
journal, September 2019

  • Matsuda, Hiroshi; Shigemoto, Yoko; Sato, Noriko
  • Japanese Journal of Radiology, Vol. 37, Issue 11
  • DOI: 10.1007/s11604-019-00867-7

In vivo demonstration of amyloid burden in posterior cortical atrophy: a case series with PET and CSF findings
journal, April 2011

  • Formaglio, Maïté; Costes, Nicolas; Seguin, Jérémie
  • Journal of Neurology, Vol. 258, Issue 10
  • DOI: 10.1007/s00415-011-6030-0

Alzheimer's disease: The next frontier—Special Report 2017
journal, April 2017


PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
journal, December 2019

  • Reimand, Juhan; de Wilde, Arno; Teunissen, Charlotte E.
  • Alzheimer's Research & Therapy, Vol. 11, Issue 1
  • DOI: 10.1186/s13195-019-0561-5

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies
journal, April 2009


Biomarkers for the Early Detection and Progression of Alzheimer’s Disease
journal, October 2016

  • Counts, Scott E.; Ikonomovic, Milos D.; Mercado, Natosha
  • Neurotherapeutics, Vol. 14, Issue 1
  • DOI: 10.1007/s13311-016-0481-z

Dementia of the Alzheimer Type
journal, May 2008

  • Jalbert, J. J.; Daiello, L. A.; Lapane, K. L.
  • Epidemiologic Reviews, Vol. 30, Issue 1
  • DOI: 10.1093/epirev/mxn008

Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid
journal, June 2013

  • Braak, Heiko; Zetterberg, Henrik; Del Tredici, Kelly
  • Acta Neuropathologica, Vol. 126, Issue 5
  • DOI: 10.1007/s00401-013-1139-0

Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia
journal, February 2019


Subtypes of progressive aphasia: application of the international consensus criteria and validation using β-amyloid imaging
journal, September 2011

  • Leyton, Cristian E.; Villemagne, Victor L.; Savage, Sharon
  • Brain, Vol. 134, Issue 10
  • DOI: 10.1093/brain/awr216

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
journal, January 2008


Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition
journal, May 2012


A metabolomic approach to identifying biomarkers in blood of Alzheimer's disease
journal, February 2019

  • Lin, Chia‐Ni; Huang, Chin‐Chang; Huang, Kuo‐Lun
  • Annals of Clinical and Translational Neurology, Vol. 6, Issue 3
  • DOI: 10.1002/acn3.726

Amyloid-β imaging with PET in Alzheimer’s disease: is it feasible with current radiotracers and technologies?
journal, October 2011

  • Moghbel, Mateen C.; Saboury, Babak; Basu, Sandip
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Issue 2
  • DOI: 10.1007/s00259-011-1960-4

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
journal, January 2012

  • Camus, V.; Payoux, P.; Barré, L.
  • European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Issue 4
  • DOI: 10.1007/s00259-011-2021-8

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
journal, July 2011

  • Toledo, Jon B.; Vanderstichele, Hugo; Figurski, Michal
  • Acta Neuropathologica, Vol. 122, Issue 4
  • DOI: 10.1007/s00401-011-0861-8

The clinical safety, biodistribution and internal radiation dosimetry of flutemetamol (18F) injection in healthy Japanese adult volunteers
journal, June 2015


Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study
journal, November 2019


Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
journal, December 2019


PET amyloid-beta imaging in preclinical Alzheimer's disease
journal, March 2012

  • Vlassenko, Andrei G.; Benzinger, Tammie L. S.; Morris, John C.
  • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Vol. 1822, Issue 3
  • DOI: 10.1016/j.bbadis.2011.11.005

A systematic review and meta‐analysis of 18 F‐labeled amyloid imaging in Alzheimer's disease
journal, March 2015

  • Yeo, Jing Ming; Waddell, Briony; Khan, Zubair
  • Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol. 1, Issue 1
  • DOI: 10.1016/j.dadm.2014.11.004

Performance of [ 18 F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease
journal, January 2017

  • Salloway, Stephen; Gamez, Jose E.; Singh, Upinder
  • Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol. 9, Issue 1
  • DOI: 10.1016/j.dadm.2017.06.001

Molecular imaging: What is right and what is an illusion?
journal, January 2018

  • Klunk, William E.
  • Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol. 10, Issue 1
  • DOI: 10.1016/j.dadm.2018.01.004

Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker
journal, May 2013

  • van Rooden, Sanneke; Versluis, Maarten J.; Liem, Michael K.
  • Alzheimer's & Dementia, Vol. 10, Issue 1
  • DOI: 10.1016/j.jalz.2013.02.002

ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide
journal, January 2017


Sugihara causality analysis of scalp EEG for detection of early Alzheimer's disease
journal, January 2015


Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome
journal, January 2018


Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load
journal, January 2018


Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
journal, January 2018


Biomathematical screening of amyloid radiotracers with clinical usefulness index
journal, September 2017

  • Nai, Ying-Hwey; Shidahara, Miho; Seki, Chie
  • Alzheimer's & Dementia: Translational Research & Clinical Interventions, Vol. 3, Issue 4
  • DOI: 10.1016/j.trci.2017.08.006

Moderate‐ to high‐intensity exercise does not modify cortical β‐amyloid in Alzheimer's disease
journal, January 2019

  • Frederiksen, Kristian S.; Madsen, Karine; Andersen, Birgitte B.
  • Alzheimer's & Dementia: Translational Research & Clinical Interventions, Vol. 5, Issue 1
  • DOI: 10.1016/j.trci.2019.04.006

β-Amyloid is Associated with Aberrant Metabolic Connectivity in Subjects with Mild Cognitive Impairment
journal, April 2014

  • Carbonell, Felix; Charil, Arnaud; Zijdenbos, Alex P.
  • Journal of Cerebral Blood Flow & Metabolism, Vol. 34, Issue 7
  • DOI: 10.1038/jcbfm.2014.66

Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease
journal, March 2016

  • Pascoal, T. A.; Mathotaarachchi, S.; Mohades, S.
  • Molecular Psychiatry, Vol. 22, Issue 2
  • DOI: 10.1038/mp.2016.37

Cerebral white matter lesions – associations with Aβ isoforms and amyloid PET
journal, February 2016

  • van Westen, Danielle; Lindqvist, Daniel; Blennow, Kaj
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep20709

Multiple imputation models should incorporate the outcome in the model of interest
journal, June 2011


Chain Link Fence Impalements in a Traffic Accident
journal, June 1986


[18F]-Florbetapir PET: Towards Predicting Dementia in Adults with Down Syndrome
posted_content, February 2018

  • Keator, David B.; Doran, Eric; Van Erp, Theo G. M.
  • DOI: 10.1101/235440

Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
journal, July 2017

  • Erkkinen, Michael G.; Kim, Mee-Ohk; Geschwind, Michael D.
  • Cold Spring Harbor Perspectives in Biology, Vol. 10, Issue 4
  • DOI: 10.1101/cshperspect.a033118

Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals
journal, October 2012

  • Lazarczyk, Maciej J.; Hof, Patrick R.; Bouras, Constantin
  • BMC Medicine, Vol. 10, Issue 1
  • DOI: 10.1186/1741-7015-10-127

Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause
journal, January 2013

  • Miller, Virginia M.; Garovic, Vesna D.; Kantarci, Kejal
  • Biology of Sex Differences, Vol. 4, Issue 1
  • DOI: 10.1186/2042-6410-4-6

Profiling of hepatic clearance pathways of Pittsburgh compound B and human liver cytochrome p450 phenotyping
journal, February 2013

  • Van Vlaslaer, Anne; Mortishire-Smith, Russell J.; Mackie, Claire
  • EJNMMI Research, Vol. 3, Issue 1
  • DOI: 10.1186/2191-219x-3-10

Assessing THK523 selectivity for tau deposits in Alzheimer’s disease and non–Alzheimer’s disease tauopathies
journal, January 2014

  • Fodero-Tavoletti, Michelle T.; Furumoto, Shozo; Taylor, Leanne
  • Alzheimer's Research & Therapy, Vol. 6, Issue 1
  • DOI: 10.1186/alzrt240

Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications
journal, November 2011

  • Laforce, Robert; Rabinovici, Gil D.
  • Alzheimer's Research & Therapy, Vol. 3, Issue 6
  • DOI: 10.1186/alzrt93

Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development
journal, January 2011

  • Nordberg, Agneta
  • Alzheimer's Research & Therapy, Vol. 3, Issue 6
  • DOI: 10.1186/alzrt96

Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting
journal, July 2016

  • Plissonneau, Marie; Pansieri, Jonathan; Heinrich-Balard, Laurence
  • Journal of Nanobiotechnology, Vol. 14, Issue 1
  • DOI: 10.1186/s12951-016-0212-y

Rates of  -amyloid accumulation are independent of hippocampal neurodegeneration
journal, April 2014


Clinical Profile of PiB-Positive Corticobasal Syndrome
journal, April 2013


Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer’s Disease Progression
journal, May 2016


Imaging Alzheimer's disease pathophysiology with PET
journal, June 2016


Blood protein predictors of brain amyloid for enrichment in clinical trials?
journalarticle, January 2015


Type 2 diabetes as a risk factor for cognitive impairment: current insights
journal, June 2014


General anesthetic and the risk of dementia in elderly patients: current insights
journal, September 2014

  • Seitz, Dallas; Hussain, Maria; Eckenhoff, Roderic
  • Clinical Interventions in Aging
  • DOI: 10.2147/cia.s49680

Diagnosing Corticobasal Syndrome Based on the Presence of Visual Hallucinations and Imaging with Amyloid Positron Emission Tomography
journal, January 2018


Asymptomatic Alzheimers Disease: A Prodrome or a State of Resilience?
journal, June 2011


Alzheimer’s Prevention Initiative: a proposal to evaluate presymptomatic treatments as quickly as possible
journal, February 2010

  • Reiman, Eric M.; Langbaum, Jessica BS; Tariot, Pierre N.
  • Biomarkers in Medicine, Vol. 4, Issue 1
  • DOI: 10.2217/bmm.09.91

Differentiating between Alzheimer Disease Patients and Controls with Phase-difference-enhanced Imaging at 3T: A Feasibility Study
journal, January 2018

  • Tateishi, Machiko; Kitajima, Mika; Hirai, Toshinori
  • Magnetic Resonance in Medical Sciences, Vol. 17, Issue 4
  • DOI: 10.2463/mrms.mp.2017-0134

Clinical Validation of 18F-AZD4694, an Amyloid-β–Specific PET Radioligand
journal, February 2012

  • Cselényi, Zsolt; Jönhagen, Maria Eriksdotter; Forsberg, Anton
  • Journal of Nuclear Medicine, Vol. 53, Issue 3
  • DOI: 10.2967/jnumed.111.094029

Imaging Biomarkers in Alzheimer’s Disease: A Practical Guide for Clinicians
journal, July 2017

  • Sheikh-Bahaei, Nasim; Sajjadi, Seyed Ahmad; Manavaki, Roido
  • Journal of Alzheimer's Disease Reports, Vol. 1, Issue 1
  • DOI: 10.3233/adr-170013

Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition
journal, July 2016

  • Kantarci, Kejal; Lowe, Val J.; Lesnick, Timothy G.
  • Journal of Alzheimer's Disease, Vol. 53, Issue 2
  • DOI: 10.3233/jad-160258

Negative 11C-PIB PET Predicts Lack of Alzheimer’s Disease Pathology in Postmortem Examination
journal, April 2018

  • Scheinin, Noora M.; Gardberg, Maria; Röyttä, Matias
  • Journal of Alzheimer's Disease, Vol. 63, Issue 1
  • DOI: 10.3233/jad-170569

Blood-brain transfer of Pittsburgh compound B in humans
journal, January 2013

  • Gjedde, Albert; Aanerud, Joel; Braendgaard, Hans
  • Frontiers in Aging Neuroscience, Vol. 5
  • DOI: 10.3389/fnagi.2013.00070

PiB Fails to Map Amyloid Deposits in Cerebral Cortex of Aged Dogs with Canine Cognitive Dysfunction
journal, January 2013


Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer’s Disease
journal, February 2017

  • Almdahl, Ina S.; Lauridsen, Camilla; Selnes, Per
  • Frontiers in Aging Neuroscience, Vol. 9
  • DOI: 10.3389/fnagi.2017.00009

Biomarkers in Alzheimer’s Disease
journal, January 2011


Cerebral Microbleeds: A Review of Clinical, Genetic, and Neuroimaging Associations
journal, January 2014


Role of Hybrid Brain Imaging in Neuropsychiatric Disorders
journal, December 2015


Plasma-Enabled Carbon Nanostructures for Early Diagnosis of Neurodegenerative Diseases
journal, June 2014

  • Pineda, Shafique; Han, Zhao; Ostrikov, Kostya
  • Materials, Vol. 7, Issue 7
  • DOI: 10.3390/ma7074896

Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimers Disease
journal, January 2016


Prevalence of dementia in a rural nursing home population in Southern Germany
journal, September 2013


Prevalence of dementia in a rural nursing home population in southern Germany
text, January 2014


Amyloid Imaging PET Ligands as Biomarkers for Alzheimer’s Disease, Preclinical Evaluation
book, February 2012

  • Svedberg, Marie; Hellstrm-Lindahl, Ewa; Rahman, Obaidur
  • Positron Emission Tomography - Current Clinical and Research Aspects
  • DOI: 10.5772/31813

Conceptual and Measurement Challenges in Research on Cognitive Reserve
text, January 2011

  • Jones, Richard; Manly, Jennifer J.; Glymour, M. Maria
  • Columbia University
  • DOI: 10.7916/d8pr97dh